South Orange, NJ

Northern New Jersey Eye Institute

Open-Angle Glaucoma

Glaucoma

Ocular Hypertension

Conjunctivitis

Hypertension

Keratitis

Dry Eye Syndromes

Presbyopia

Keratoconjunctivitis Sicca

Eye Diseases

Timolol Maleate

DE-126

iodine

DE-117

Iodine

Travoprost

Povidone

Glaukos

Santen

Shire

Bausch + Lomb

BioTissue Holdings, Inc

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The purpose of this randomized, controlled, multicenter study is to evaluate the safety and efficacy of TTAX03 in participants with mild to moderate DED.

The primary question it aims to answer is if TTAX03 is safe. The secondary is the effectiveness.

Researchers will compare 10mg of TTAX03 reconstituted in 150, 300, or 600 uL saline to the saline control group to look at effectiveness.

Participants will be randomized to a treatment group one time and be evaluated at 5 different study visits.

A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

Northern New Jersey Eye Institute | South Orange, NJ

Site insights

Work at this site?

Active trials

A Study in the Treatment of Mild to Moderate Dry Eye Disease Comparing Saline to TTAX03.

Trial sponsors